organophosphonates has been researched along with Brain Edema in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, Y; Han, W; Hao, J; Huang, D; Liu, Q; Shen, Y; Sheth, KN; Shi, FD; Shi, K; Sun, N; Wood, K | 1 |
| Chang, CZ; Howng, SL; Jeng, AY; Kassell, NF; Kwan, AL; Lin, TK; Winadi, D; Wu, SC; Yen, CP | 1 |
2 other study(ies) available for organophosphonates and Brain Edema
| Article | Year |
|---|---|
Selective Sphingosine-1-Phosphate Receptor 1 Modulation Attenuates Experimental Intracerebral Hemorrhage.
Topics: Anilides; Animals; Apoptosis; Blood-Brain Barrier; Brain Edema; Cerebral Hemorrhage; Cytokines; DNA-Binding Proteins; Drug Evaluation, Preclinical; Lymphocyte Subsets; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microglia; Neurons; Organophosphonates; Receptors, Lysosphingolipid; Sphingosine-1-Phosphate Receptors | 2016 |
Neuroprotective effect of CGS 26303, an endothelin-converting enzyme inhibitor, on transient middle cerebral artery occlusion in rats.
Topics: Animals; Aspartic Acid Endopeptidases; Behavior, Animal; Brain; Brain Edema; Disease Models, Animal; Drug Administration Schedule; Endothelin-Converting Enzymes; Infarction, Middle Cerebral Artery; Injections, Intravenous; Male; Metalloendopeptidases; Neuroprotective Agents; Organophosphonates; Protease Inhibitors; Rats; Rats, Sprague-Dawley; Tetrazoles | 2004 |